Immucor Completes $715 Million Acquisition Financing
Date: 08/19/11
Cahill represented Citibank as administrative agent and Citigroup and J.P. Morgan Securities as lead arrangers in connection with the $715,000,000 credit facility, comprised of a $615,000,000 Term B Loan, a $50,000,000 Revolving credit facility and a $50,000,000 alternative currency revolver for Immucor, Inc., a maker of systems used in blood transfusions. The proceeds will be used to partially finance the acquisition of Immucor by TPG Capital.